RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors

Erik C. Dreaden(Massachusetts Institute of Technology), Paula T. Hammond(Institute for Soldier Nanotechnologies)
Bioengineering & Translational Medicine
January 1, 2018
Cited by 16


Related Papers